These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6682617)
21. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088 [TBL] [Abstract][Full Text] [Related]
22. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect. Beekman RH; Rocchini AP; Rosenthal A Circulation; 1982 Mar; 65(3):523-8. PubMed ID: 6459891 [TBL] [Abstract][Full Text] [Related]
23. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Smucker ML; Sanford CF; Lipscomb KM Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708 [TBL] [Abstract][Full Text] [Related]
24. Vasodilator therapy for chronic left ventricular failure. Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614 [TBL] [Abstract][Full Text] [Related]
25. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Miller AB; Conetta DA; Bass TA Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570 [TBL] [Abstract][Full Text] [Related]
26. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. Elkayam U; Weber L; McKay CR; Rahimtoola SH Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802 [TBL] [Abstract][Full Text] [Related]
27. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure. Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874 [TBL] [Abstract][Full Text] [Related]
28. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945 [TBL] [Abstract][Full Text] [Related]
29. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384 [TBL] [Abstract][Full Text] [Related]
30. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238 [TBL] [Abstract][Full Text] [Related]
31. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure. Daly P; Rouleau JL; Cousineau D; Burgess JH; Chatterjee K Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637 [TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of intravenous isosorbide dinitrate and nitroglycerine in acute myocardial infarction and elevated pulmonary artery wedge pressure. Roth A; Weber L; Freidenberger L; Rahimtoola SH; Elkayam U Chest; 1987 Feb; 91(2):190-6. PubMed ID: 3100145 [TBL] [Abstract][Full Text] [Related]
33. Isosorbide dinitrate in acute and chronic heart failure. Venkataraman K; Durairaj SK; de Guzman M; Haywood LJ Clin Pharmacol Ther; 1979 Jan; 25(1):43-50. PubMed ID: 758242 [TBL] [Abstract][Full Text] [Related]
34. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure. Stephens JD; Banim SO; Spurrell RA Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716 [TBL] [Abstract][Full Text] [Related]
35. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction. Bussmann WD; Löhner J; Kaltenbach M Am J Cardiol; 1977 Jan; 39(1):91-6. PubMed ID: 318796 [TBL] [Abstract][Full Text] [Related]
36. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. Cohn JN; Tam SW; Anand IS; Taylor AL; Sabolinski ML; Worcel M; J Card Fail; 2007 Jun; 13(5):331-9. PubMed ID: 17602978 [TBL] [Abstract][Full Text] [Related]
37. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of vasodilators and long-term response in heart failure. Franciosa JA; Dunkman WB; Leddy CL J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522 [TBL] [Abstract][Full Text] [Related]
39. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration. Leier CV; Huss P; Magorien RD; Unverferth DV Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218 [TBL] [Abstract][Full Text] [Related]
40. [Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)]. Wolf R; Beck OA; Habel F; Hochrein H Z Kardiol; 1977 Aug; 66(8):459-64. PubMed ID: 899150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]